posted Soligenix Enters Q4 With Multiple Catalysts in Play Newsfile Corp. Thu, October 13, 2022 at 5:30 AM·4 min read In this article:
New York, New York--(Newsfile Corp. - October 13, 2022) - PCG Digital -- Late-stage biopharmaceutical company, Soligenix, Inc. (NASDAQ: SNGX) is anticipating significant catalysts in Q4 and a potentially transformational year in 2023.
posted